Madsen, C.
, Lauridsen, K. L., Plesner, T. L., Monrad, I.
, Honoré, B., Hamilton-Dutoit, S., d’Amore, F. & Ludvigsen, M. (2019).
High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma.
Blood Cancer Journal,
9(4), Article 35.
https://doi.org/10.1038/s41408-019-0197-5
Ludvigsen, M., Vase, M. Ø., Bendix, K.
, Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S. & D'Amore, F. A. (2016).
High Intratumoral Expression of Galectin-1 Correlated with Superior Outcome in HIV-associated DLBCL..
D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkiaer, E., Vornanen, M. & Toldbod, H. (2012).
High-dose chemotherapy and autologous stem cell transplantation in previously untreated peripheral T-cell lymphoma - final analysis of a large prospective multicenter study (NLG-T-01).
Blood,
118, 331.
D'Amore, F. A., Relander, T., Lauritzen, G. F., Jantunen, E., Mannisto, S., Meyer, P., Ellin, F.
, Pedersen, M. B. & Toldbod, H. (2016).
Hematopoietic stem-cell transplantation in peripheral T-cell lymphomas. In
Hematopoietic cell transplants - Concepts, controversies and future directions Cambridge University Press.
Massa, G., Bogliolo, G.
, d'Amore, F. A., Muzzulini, C., Ghio, R. & Pannacciulli, I. (1982).
Haemopoietic precursor cells in mice treated with 4-demethoxydaunorubicin and doxorubicin.
Journal of the National Cancer Institute,
68, 971-976.
Monrad, I., Madsen, C.
, Lauridsen, K. L., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S., D’Amore, F. & Ludvigsen, M. (2020).
Glycolytic biomarkers predict transformation in patients with follicular lymphoma.
PLOS ONE,
15(5), Article e0233449.
https://doi.org/10.1371/journal.pone.0233449
de Leval, L., Alizadeh, A. A., Bergsagel, P. L., Campo, E., Davies, A., Dogan, A., Fitzgibbon, J., Horwitz, S. M., Melnick, A. M., Morice, W. G., Morin, R. D., Nadel, B., Pileri, S. A., Rosenquist, R., Rossi, D., Salaverria, I., Steidl, C., Treon, S. P., Zelenetz, A. D. ... Scott, D. W. (2022).
Genomic profiling for clinical decision making in lymphoid neoplasms.
Blood,
140(21), 2193-2227.
https://doi.org/10.1182/blood.2022015854
Dybkær, K., Iqbal, J., Zhou, G., Geng, H., Xiao, L.
, Schmitz, A., d'Amore, F. A. & Chan, W. C. (2007).
Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: Gene expression signatures indicative of novel molecular signaling pathways. BMC Gemomics.
BMC Gemomics,
8(230).
Heavican, T. B., Bouska, A., Yu, J., Lone, W. G., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B. J., Nairismägi, M.-L., Greiner, T. C., Vose, J., Weisenburger, D. D., Lachel, C., Wang, C., Fu, K., Stevens, J., Lim, S. T., Ong, C. K. ... Iqbal, J. (2019).
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Blood,
133(15), 1664-1676.
https://doi.org/10.1182/blood-2018-09-872549
Petruskevicius, I.
, Ludvigsen, M., Kamper, P. M. H., Hjortebjerg, R.
, Sørensen, B. S., Nielsen, B., Honoré, B.
& D'Amore, F. A. (2014).
Galectin-1 as a novel prognostic biomarker in haematologic malignancies treated with non-myeloablative haemopoietic stem cell transplantation.. Poster session presented at European Group for Blood and Marrow Transplantation Annual Meeting, Milano, Italy.
Petruskevicius, I.
, Ludvigsen, M., Kamper, P., Hjortebjerg, R.
, Sørensen, B. S., Nielsen, B.
, Honoré, B. & d'Amore, F. A. (2014).
Galectin-1 as a novel biomarker in haematologic malignancies treated with non-myeloablative haematopoietic stem cell transplantation.
Kucuk, C., Jiang, B., Hu, X., Gaulard, P., Zhang, W., Xiao, W., Staudt, LM., Iqbal, J., Cornish, A., Kavak, P., Alkan, C., Gong, Q., Yang, Q., Sun, H.
, D'Amore, F. A., Leppa, S., Liu, W., McKeithan, T. & Chan, WC. (2013).
Frequent activating mutations of JAK-Stat Pathway genes in natural killer cell lymphomas.
Blood.
Kelsen, J., Dige, A., Christensen, M.
, D'Amore, F. & Iversen, L. (2014).
Frequency and clonality of peripheral γδ T cells in psoriasis patients receiving anti-TNF-α therapy.
Clinical and Experimental Immunology,
177(1), 142–148.
https://doi.org/10.1111/cei.12331
Pedersen, M. A.
, Gormsen, L. C., Kamper, P., Wassberg, C., Andersen, M. D., d'Amore, A. L., Barrington, S. F., Johnson, P.
, Hamilton-Dutoit, S., Amini, R. M., Enblad, G., Molin, D.
& d'Amore, F. (2019).
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy.
British Journal of Haematology,
186(3), 431-439.
https://doi.org/10.1111/bjh.15933
D'Amore, F. A., Gomes da Silva, M., Leppa, S., Relander, T., Pezzutto, A., Lauritzsen, GF., Weidmann, E., Van Gelder, M., Merup, M., Hagberg, H., Fagerli, UM., Brown, P. D. N., Boye Hansen, P., Mariz, JM., Jankovska, M., Walewski, J., Doorduijn, J., van Hoof, A.
, Christiansen, I. ... Toldbod, H. (2011).
First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant. Blood,
118, 4110.
D'Amore, F. A., Leppä, S., Gomes da Silva, M., Relander, T., Brown, P. D. N., Weidmann, E., Lauritzsen, GF., Pezzutto, A., Van Hoof, A., Van Gelder, M., Doorduijn, J., Wu, KL., Kluin-Nelemans, JC., Lugtenburg, PJ., Jankovska, M., Merup, M., Fagerli, U.-M., Walewski, J., Hagberg, H. ... Toldbod, H. (2012).
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma PatientsTreated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy.
Blood,
120(57).
Pedersen, M. B., Hamilton Dutoit, S. J., Bendix, K., Ketterling, RP., Bedroske, PP., Luoma, IM., CA, S., Bennani-Baiti, N., Nørgaard, P., Møller, MB.
, Steiniche, T. & d'Amore, F. A. (2017).
First independent validation fo DUSP22 and TP63 rearrangements as outcome predictors in ALK-negative anaplastic large cell lymphoma: a Danish cohort study. Blood.
Hansen, G. A. W.
, Ludvigsen, M., Jacobsen, C., Cangemi, C., Rasmussen, L. M., Vorum, H.
& Honoré, B. (2015).
Fibulin-1C, C1 esterase inhibitor and glucose regulated protein 75 interact with the CREC proteins, calumenin and reticulocalbin.
P L o S One,
10, Article e0132283.
Relander, T., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2010).
favorable outcome in ALK-negative anaplastic large-cell lymphoma following intensive induction chemotherapy and autologous stem cell transplantation (ASCT): a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21).
Meier, M., Andersen, K. J., Knudsen, A. R., Ludvigsen, M., Honoré, B. & Mortensen, F. V. (2016).
Extended hepatectomy induces pronounced changes in protein expression levels..
Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A., Karkkainen, M. J., Tainola, T.
, Sørensen, A. B., Pedersen, F. S. & D'Amore, F. (2009).
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Leukemia and Lymphoma,
50(10), 1647-1660.
https://doi.org/10.1080/10428190903156729,
https://doi.org/10.1080/10428190903156729
Christensen, M. H., Hansen, J., Ramlau-Hansen, C., Toft, G.
, D'Amore, F. A. & Kolstad, H. (2014).
Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry. Occupational & Environmental Medicine,
71(Suppl 1).
Rosenberg, C. A., Bill, M., Rodrigues, M. A., Hauerslev, M., Kerndrup, G. B.
, Hokland, P. & Ludvigsen, M. (2021).
Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
Cytometry. Part B: Clinical Cytometry,
100(5), 554-567.
https://doi.org/10.1002/cyto.b.21975
Muzzulini, C.
, d'Amore, F. A., Sobrero, A., Massa, G., Bogliolo, G., Ghio, R. & Pannacciulli, I. (1981).
Evaluation of doxorubicin toxicity on normal haemopoietic stem cells.
Tumori,
67, 293-300.
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., Nørgaard, P., Johansen, P., Ralfkiaer, E., Brown, P. D. N., Hansen, P. B., Jensen, B. A., Madsen, J., Schöllkopf, C.
& d'Amore, F. (2014).
Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
Hematological Oncology (Online),
33(4), 120-128.
https://doi.org/10.1002/hon.2153
Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D.
, d'Amore, F., Haioun, C., Thieblemont, C., González-Barca, E., Grande García, C., Johnson, P. W., van Imhoff, G. W., Ng, T., Dwyer, K. & Morschhauser, F. (2016).
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.
Haematologica,
101(10), e407-e410.
https://doi.org/10.3324/haematol.2016.146977
Olsson, L., Behnke, O., Pleibel, N.
, d'Amore, F. A., Werdelin, O., Fry, KE. & Kaplan, HS. (1984).
Establishment and characterization of a giant cell line from a patient with Hodgkin's disease.
Journal of the National Cancer Institute,
73, 809-30.
Ghielmini, M., Vitolo, U., Kimby, E., Montoto, S., Walewski, J., Pfreundschuh, M., Federico, M., Hoskin, P., McNamara, C. M., Caligaris-Cappio, F., Stilgenbauer, S., Marcus, R., Trneny, M., Dreger, P., Montserrat, E., Dreyling, M., Agostinelli, C., Arcaini, L., Campo, E. ... Zucca, E. (2013).
Esmo Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).
Annals of Oncology,
24(3), 561-76.
Kamper, P., Bendix, K.
, Honoré, B., D'Amore, F. A. & Hamilton-Dutoit, S. J. (2012).
Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, GA, United States.
Kamper, P., Bendix, K.
, Hamilton-Dutoit, S. J., Honoré, B. & D'Amore, F. A. (2012).
Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma.
Blood,
120(21), Article 120.
d'Amore, F. A., Johansen, P., Houmand, A., Weisenburger, DD. & Mortensen, L. (1996).
Epstein-Barr virus genome in non-Hodgkin's lymphomas occuring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood,
87((3)), 1045-55.
Kamper, P., Kjeldsen, E., Clausen, N., Bendix, K.
, Hamilton-Dutoit, S. & d'Amore, F. (2005).
Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.
British Journal of Haematology,
129(5), 615-7.
https://doi.org/10.1111/j.1365-2141.2005.05499.x
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Maryalice, S. S., Pittaluga, S., Jaffe, E. S. & Wilson, W. H. (2012).
Efficacy of alemtuzumab (ALZ) in combination with dose-ajusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma.
Journal of Clinical Oncology,
30(15).
Bro, M. L., Johansen, C.
, Vuust, P., Enggaard, L., Himmelstrup, B., Mourits-Andersen, T., Brown, P.
, d'Amore, F., Andersen, E. A. W., Abildgaard, N. & Gram, J. (2019).
Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
27(10), 3887-3896.
https://doi.org/10.1007/s00520-019-04666-8
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Ketterling, R. P., Bedroske, P. P., Luoma, I. M., Sattler, C. A., Boddicker, R. L., Bennani, N. N., Nørgaard, P., Møller, M. B.
, Steiniche, T., d'Amore, F. & Feldman, A. L. (2017).
DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.
Blood,
130(4), 554-557.
https://doi.org/10.1182/blood-2016-12-755496
Neldeborg, S., Soerensen, J. F., Møller, C. T., Bill, M., Gao, Z.
, Bak, R. O., Holm, K.
, Sorensen, B., Nyegaard, M.
, Luo, Y., Hokland, P., Stougaard, M., Ludvigsen, M. & Holm, C. K. (2023).
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.
Leukemia,
37(9), 1792-1801.
https://doi.org/10.1038/s41375-023-01950-9
Herek, T. A., Bouska, A., Lone, W., Sharma, S., Amador, C., Heavican, T. B., Li, Y., Wei, Q., Jochum, D., Greiner, T. C., Smith, L., Pileri, S., Feldman, A. L., Rosenwald, A., Ott, G., Lim, S. T., Ong, C. K., Song, J., Jaffe, E. S. ... Iqbal, J. (2022).
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Blood,
140(11), 1278-1290.
https://doi.org/10.1182/blood.2021015019
Møller, M., Rath, M. F.
, Ludvigsen, M., Honoré, B. & Vorum, H. (2017).
Diurnal expression of proteins in the retina of the blind cone-rod homeobox (Crx(-/-) ) mouse and the 129/Sv mouse: a proteomic study.
Acta Ophthalmologica,
7(95), 717-726.
https://doi.org/10.1111/aos.13429
El-Galaly, T. C., Juul Mylam, K., Brown, P. D. N., Bukh, A., Johnsen, H. E., Madsen, C.
, D'Amore, F. A. & Hutchings, M. (2012).
Disease Extent in Newly Diagnosed Hodgkin Lymphoma: A Comparison of CT and PET/CT Staged Patients.
Pedersen, M. B., Riber-Hansen, R.
, Nielsen, P. S., Bendix, K.
, Hamilton-Dutoit, S. J., D'Amore, F. & Steiniche, T. (2014).
Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomas.
Applied Immunohistochemistry & Molecular Morphology,
22(8), 577-84.
https://doi.org/10.1097/PAI.0b013e3182a7d16d
Gormsen, L. C., Wassberg, C., Molin, D., Kamper, P. M. H., Enblad, G.
& D'Amore, F. A. (2014).
Diffusely increased bone marrow 18F-FDG uptake is an independent predictor of focal bone lesions in patients with newly diagnosed classical Hodgkin Lymphoma.
Blood,
124(21).
Ludvigsen, M., Kamper, P., Sørensen, B. S., Møller, M. B., Bendix, K.
, Hamilton-Dutoit, S. J., Alsner, J., D'Amore, F. A. & Honoré, B. (2015).
Differential protein expression of peroxiredoxin-1 in classical Hodgkin Lymphoma: a possible correlation to clinical behaviour.
Hematological Oncology,
33, 253-255.
https://doi.org/10.1002/hon.2157
Vase, M. Ø., Hellberg, Y. K.
, Larsen, C. S., Petersen, E., Schaumburg, H., Bendix, K., Ravel, C., Bastien, P., Christensen, M.
& d'Amore, F. (2012).
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Acta Haematologica Polonica,
128(1), 20-2.
https://doi.org/10.1159/000337341
Vase, M. Ø., Hellberg, YK., Larsen, CS., Schaumburg, H., Bendix, K., Ravel, C., Bastien, P., Nyvold, C. G., Christensen, M.
& D'Amore, F. A. (2011).
Development of splenic marginal zone lymphoma associated with active chronic visceral leishmaniasis. Blood,
118, 5202.